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(p=0.08). In a mean follow up of 5.5 years, there were 215 (48%) deaths. Statin therapy
was associated with improved long-term survival (p=0.004) on Cox hazard regression,
controlling for comorbidities, age, beta-blocker use, and operative year. Conclusion:
Preoperative statin therapy is associated with a shorter length of stay, improved long-
term survival, and a trend towards fewer perioperative CV complications in pts undergo-
ing infra-inguinal vascular surgery.
1046-172 Usefulness of Plasma Fibrin D-Dimers for 
Differentiation of Acute Versus Chronic Aortic 
Dissection
Holger Eggebrecht, Christoph K. Naber, Axel Schmermund, Clemens von Birgelen, Marc 
Wichert, Thomas Bartel, Klaus Mann, Raimund Erbel, University Essen, Essen, 
Germany
Background: Discrimination between acute and chronic aortic dissection (AD) has
important prognostic and therapeutic implications, but is frequently difficult in the clinical
setting. This study evaluated the usefulness of plasma fibrin D-dimer levels and biomark-
ers of inflammation to differentiate between acute and chronic AD.
Methods and Results: Blood samples from 38 consecutive patients with acute (group 1,
n=12) and chronic (group 2, n=26) AD were tested for plasma fibrin D- dimers, white
blood cell (WBC) count, C- reactive protein (CRP), and fibrinogen. White blood cell count
and CRP levels were significantly higher in group 1 compared to group 2 (15.4±4.7 x 109/
l vs. 8.1±2.2 x 109/l, p<0.001; and 88±74 mg/l vs. 24±38 mg/l, p=0.001, respectively),
with considerable overlap between both groups. Group 1 patients had significantly higher
levels of plasma D-dimers compared to group 2 patients (2094±1562 µg/l vs. 275±170µg/
l, p<0.001). ROC curve analysis yielded an optimal cutoff value of 627 µg/l for D-dimer
levels with a sensitivity of 100% and specificity of 96% for the presence of an acute dis-
ease state of AD.
Conclusion: Measurement of D-dimers is a widely available laboratory test which allows
to discriminate between acute and chronic AD with high accuracy once the diagnosis has
been made. 
1046-173 Prevalence and Clinical Correlates of Symptomatic 
Peripheral Arterial Disease in Italy
Gabriella Oliva, Antonio Silvestro, AnnaMaria Di Donato, Antonietta Di Iorio, Gregorio 
Brevetti, Massimo Chiariello, Peripheral Arteriopathy and Cardiovascular Events(PACE) 
Study Group, University, Napoli, Italy
Background. Epidemiology of peripheral arterial disease (PAD) was studied almost
exclusively in Northern European and Northern American populations. Thus, it is unclear
what is the magnitude of the problem in other countries. We report the first survey in Italy
to describe the prevalence of symptomatic PAD and its relationship with cardiovascular
risk factors and other diseases.
Methods. From the lists of 7 general practitioners, all subjects living in a well defined
area of Southern Italy were identified who were aged 40-80 years (n=4352). All of them
received a Rose questionnaire (RQ) which was completed by 3699 subjects. In those
referring pain in the calf that began while walking and did not disappear continuing to
walk, regardless of whether the other Rose criteria were met (n=760), ankle/brachial
index (ABI) was measured, and the presence of PAD defined by ABI < 0.90.
Results. The prevalence of symptomatic PAD was 1.6% (2.4% in men, 0.9% in women).
For each PAD patient, 3 controls matched for sex and age were selected randomly from
the listing for each general practitioner. At the multivariate analysis, smoking (OR 3.7,
95% CI 1.7-8.0; p < .01), diabetes mellitus (OR 3.6, 95% CI 1.7-7.6; p < .01) and hyper-
tension (OR 3.3, 95% CI 1.4-7.8; p < .01) were associated with PAD. A coexistent cardio-
vascular disease was found in 48% of patients and 17% of controls (OR 4.6, 95% CI 2.4-
8.8; p < .01). At the multivariate analysis, only PAD was significantly associated with a
previous cardiovascular event (OR 7.8, 95% CI 2.8-21.4; p < .01). Of all cases of symp-
tomatic PAD, 45% were unaware of their condition. No significant difference was
observed between known and unknown cases.
Conclusion. This study seems to indicate that both prevalence and cardiovascular
comorbidity of symptomatic PAD in Italy are lower than in Northern European and North-
ern American countries. Moreover, the finding that, PAD was unrecognized in about 50%
of affected individuals suggest that many patients accept leg complaints as a normal fea-
ture of ageing, and imply that a large proportion of PAD population is not given preventive
therapy, so remaining at high cardiovascular risk. Thus, there is need to alert general
practitioners to this topic.
1046-174 The Pivotal Link Between Hepatitis C Virus Infection 
and Increased Arterial Stiffness in Patients With End 
Stage Renal Failure
Nobuyuki Oyake, Toshio Shimada, Yo Murakami, Yutaka Ishibashi, Harumi Katoh, Shin-
ichi Inoue, Yoko Ohta, Shimane Medical University, Izumo, Japan
Background: Recent reports have been emphasized a link between infection with micro-
organism such as Chlamydia pneumoniae and cytomegalovirus, and an increased risk of
cardiovascular and cerebrovascular diseases. Although the high prevalence of hepatitis
C virus (HCV) infection in patients with end stage renal failure (ESRF) has been well-
known, the role of HCV in pathogenesis of these atherosclerotic diseases is unclear. It
has been recently reported that aortic pulse wave velocity (PWV), a marker of arterial
stiffness, is a major predictor of mortality in ESRF patients. In this study, we evaluate the
relationship of aortic PWV and HCV infection in patients with ESRF. Methods: Seventy-
six outpatients (mean age: 64 years, 59 male, mean duration of dialysis treatment: 3517
days) undergoing chronic dialysis treatment in single center were examined. We mea-
sured their blood pressure and aortic PWV by VaSera VS-1000 (FUKUDA DENSHI,
Japan), left ventricular mass index (LVMI) by echocardiography, serum HCV-RNA by RT-
PCR, and plasma brain natriuretic peptide (BNP) by highly sensitive RIA. Determinants
of aortic PWV were analyzed by multiple stepwise regression analysis. Results: Twenty
patients (26%) were seropositive for HCV, and twelve patients (16%) had HCV viremia.
Aortic PWV was significantly higher in patients with HCV viremia than those without it
(11.7+/-3.0 vs. 9.7+/-2.2 m/sec, p<0.01). Serum transaminase levels were within normal
limits in both groups. Using simple regression analysis, aortic PWV correlated signifi-
cantly with age (r2=0.21, p<0.0001), HbA1c (r2=0.32, p<0.0001), mean blood pressure
(r2=0.26, p<0.0001), and did not correlate with duration of dialysis treatment, total cho-
lesterol, C-reactive protein, creatinine, calcium X phosphorus product. Multiple regres-
sion analysis indicated that independent determinants of aortic PWV were age (ß=0.08,
p<0.0001), HbA1c (ß=1.09, p<0.0001), mean blood pressure (ß=0.05, p<0.0001), and
the presence of HCV-RNA (ß=2.03, p<0.0001) (multiple R=0.88). Conclusion: These
data show for the first time that HCV infection is strongly associated with the progression
of atherosclerosis in patients with ESRF.
1046-175 Severe Renal Artery Stenosis Is Common in Patients 
With Severe Thoracic Aortic Plaque
Harmony R. Reynolds, Ricardo J. Benenstein, Navin C. Nakra, Alan Shah, Daniel M. 
Spevack, Itzhak Kronzon, Paul A. Tunick, NYU School of Medicine, New York, NY
Background: Atherosclerotic renal artery stenosis (RAS) is an underdiagnosed disorder,
and is a potentially treatable etiology of hypertension and renal insufficiency. RAS may be
a manifestation of generalized atherosclerosis. This study investigates the association of
RAS, as detected by abdominal duplex ultrasonography, and thoracic aortic plaque, as
detected by transesophageal echocardiography.
Methods: All pts were referred for transesophageal echocardiography for various clinical
indications. Abdominal duplex ultrasound was performed on 67 patients: 42 with severe
thoracic aortic plaque (>= 4 mm) and 25 controls. The prevalence of RAS was deter-
mined in both groups. Severe RAS (>= 60%) was defined as flow velocity > 1.8 m/sec
and renal:aortic velocity ratio >= 3.5. Clinical data regarding a history of hypertension,
coronary artery disease, diabetes mellitus, smoking, dyslipidemia, stroke and peripheral
embolization were recorded.
Results: The overall average age of the pts was 72.6 ± 9.7 yrs (57% male). There were 8
cases of RAS identified (all severe), all of them in the group of 42 patients with severe
thoracic aortic plaque (19% vs. 0% with <= 2mm plaque; P = 0.02). In a paired analysis,
matched for age and sex (McNemar), severe plaque was highly significantly associated
with RAS (P = 0.008). On univariate analysis, severe plaque (P = 0.001) and hyperten-
sion (P = 0.05) were correlated with RAS. On multivariate analysis (with plaque, hyper-
tension, dyslipidemia and smoking in the model), severe plaque (P = 0.001) and
hypertension (P = 0.05) remained independently correlated with RAS.
Conclusions: 1. Severe thoracic aortic plaque is strongly associated with RAS.
2. Pts found to have severe thoracic aortic plaque on TEE should be screened for RAS.
1046-176 Preoperative Hemodynamic Status as a Predictor of 
Surgical Mortality in Acute Type A Aortic Dissection 
Patients: Insights From the International Registry of 
Acute Aortic Dissection (IRAD)
Santi Trimarchi, Rossella Fattori, Christoph A. Nienaber, Jeanna V. Cooper, Dean E. 
Smith, Vincenzo Rampoldi, Giuseppe Sangiorgi, Truls Myrmel, Toru Suzuki, Jae K. Oh, 
Eric M. Isselbacher, Kim A. Eagle, Istituto Policlinico S. Donato, S. Donato Milanese, Italy, 
University of Michigan Medical Center, Coordinating Center for IRAD Investigators, Ann 
Arbor, MI
Background: Pre-operative hypotension or shock are known to predict adverse surgical
outcomes in patients with acute type A aortic dissection (AAD). However, data evaluating
preoperative hemodynamic status from onset of symptoms to surgery in large numbers
of patients in the modern era are limited.
Methods: We categorized 526 patients (pts) submitted to surgery for AAD among 1032
pts enrolled in the IRAD between 1996 to 2001. Preoperative hemodynamic status was
assessed at the clinical presentation of AAD, after hospitalization in the referral center
and at surgery using standard Chi-square test or Student’s T-test. These were correlated
with in-hospital mortality.
Results: Data are showed in the table. Our study highlights the importance of hypoten-
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sion as a major preoperative risk factor for mortality in AAD pts. Pts bearing severe
hypotension from the onset of symptoms to surgery have a worse mortality rate than
those that who do not (42.3% vs 13.5%, p<0.0001).
Conclusions: Our study provides information regarding the importance of preoperative
hemodynamic status, from symptom onset to surgery, as a predictor of mortality in AAD
pts. Knowledge about temporal variations of these parameters may help surgeons in
making treatment decisions among high-risk patients being considered for potentially
heroic surgical attempts.
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The Answer Is in the Lipid Fractions
Sunday, March 07, 2004, 3:00 p.m.-5:00 p.m.
Morial Convention Center, Hall G
Presentation Hour: 3:00 p.m.-4:00 p.m.
1047-177 Significant Lipid Changes in a Large-Scale Trial of 
Fenofibrate to Prevent Cardiovascular Disease in Type 2 
Diabetes
Anthony C. Keech, James D. Best, Russell S. Scott, Philip J. Barter, R. John Simes, Peta 
Forder, Marja-Riitta Taskinen, The FIELD Study Investigators, NHMRC Clinical Trials 
Centre, The University of Sydney, Sydney, Australia
Background: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) trial
is a randomized controlled trial designed to test the effects of a long-term increase in
high-density lipoprotein cholesterol (HDL-C) and decrease in triglycerides (TG) with
fenofibrate therapy on coronary heart disease (CHD) events and mortality in diabetes.
Methods: The FIELD trial included 9,795 type 2 diabetic patients (50-75 years; total cho-
lesterol 3.0-6.5 mmol/L), who received either micronized fenofibrate 200 mg or placebo
daily for > 5 years, and could start lipid-lowering therapy (including statin treatment) at
any time after randomization. The median follow-up is over 3.3 years, with an estimated
500 major coronary events (fatal CHD and nonfatal myocardial infarction) accruing in 5
years.
Results: Baseline characteristics. 
Fenofibrate (6 week run-in) reduced total cholesterol 10.4%, low-density lipoprotein cho-
lesterol 9.8%, and TG 25.2%, and increased HDL-C 6.5%. These changes reflect those
seen in the Veterans Affairs-HDL Intervention Trial (VA-HIT), in which gemfibrozil
reduced total cholesterol 4.0% and TG 31%, and increased HDL-C 6.0% after 12
months.
Conclusion: In the FIELD trial, the largest primary prevention study in type 2 diabetic
patients, fenofibrate therapy led to substantial beneficial changes in the diabetic lipid pro-
file, consistent with those seen in the VA-HIT. The FIELD trial will clarify the benefits of
fibrate therapy on lipid modification and CHD prevention in type 2 diabetes.
1047-178 Low-Density Lipoprotein Subfractions in a Random 
Sample of Children and Adolescents
Karen Olson, Bryan Hendricks, Kirk Jenkins, Sharon Fox, Mary Roth, Patrick Hughes, 
David K. Murdock, Cardiovascular Research and Education Foundation, Inc, Wausau, 
WI, Community Health Care/Wausau Health Foundation, Wausau, WI
Background: The Wausau SCHOOL Project is a community-based effort to assess the
frequency of cardiovascular risk factors in students in the Wausau School District. Lipo-
protein sub-fraction studies in adults have demonstrated that a preponderance of small
dense LDL particles (Pattern B) is associated with obesity, decreased HDL levels, insulin
resistance (IR) and increased risk of heart disease. Limited information is available on
lipoprotein sub-fractions in children and young adults. Objective: Describe the frequency
of pattern B (PB) in students and assess its relationship to age and sex adjusted body
mass index (BMI), IR, HDL and triglyceride levels. Methods: Lipid profiles and lipopro-
tein sub-fractions were measured in 586 randomly selected students from grades 2, 5, 8
and 11, using a magnetic resonance method (LipoScience®). PB was defined as mean
particle size <20.6nm. IR was assessed in 2nd and 11th graders by the homeostasis
model assessment of insulin resistance (HOMA-IR). Overweight was defined as age and
sex adjusted BMI > 85th centile based on 2000 CDC norms. Results: The incidence of
PB increased nearly 4-fold across the 4 tested grades (2.2% in 2nd grade, 5.6% in 5th
grade, 4.9% in 8th grade and 8.7% in 11th grade). Those demonstrating PB had signifi-
cantly lower HDL, higher triglycerides, LDL particle number, HOMA-IR and BMI, but not
higher total or LDL cholesterol levels. Students with PB had an average BMI at the 81.6
centile of the CDC norms, whereas those with non-PB were at the 63.9rd centile. Nearly
32% were overweight, ranging from 27.6% (2nd grade) to 37.4% (8th grade). Conclu-
sions: The frequency of PB increases with age. As seen in adults, PB in youth is associ-
ated with IR, higher triglycerides, decreased HDL levels and high BMI.
1047-179 Serum Triglycerides and the Risk of Cardiovascular 
Disease in the Asia Pacific Region: An Individual 
Participant Data Meta-Analysis of Cohort Studies 
Including 96,130 Individuals
Anushka Patel, Mark Woodward, Federica Barzi, Dongfeng Gu, Hirotsugu Ueshima, for 
the Asia Pacific Cohort Studies Collaboration, Institute for International Health, University 
of Sydney, Sydney, Australia
Background: The importance of serum triglyceride levels as an independent risk factor
for cardiovascular diseases is controversial.
Methods: We performed an individual participant data meta-analysis of prospective
studies conducted in the Asia-Pacific region. Cox models were applied to the combined
data from 26 studies to estimate the overall and region-, sex-, and age-specific hazard
ratios for major cardiovascular diseases by fifths of triglyceride values.
Results: During 795,929 person-years of follow-up among 96,130 individuals, 638
deaths due to coronary heart disease and 667 stroke deaths were recorded. After adjust-
ment for major cardiovascular risk factors and correction for regression dilution, each 1
mmol/L higher level of usual triglyceride level was associated with a 34% (95% CI 14-
58%) greater risk of coronary death. There was clear evidence of an association between
triglycerides and ischaemic stroke risk, but not with risk of haemorrhagic stroke. The
association between triglycerides and coronary death was similar when stratified by age
or sex, but there was a trend towards a stronger association in Australia / New Zealand
compared with Asian cohorts (hazard ratio for 1 mmol/L higher usual triglyceride level
1.54 [95%CI:1.26-1.89] vs. 1.12[95%CI:0.86-1.45], p=0.06).
Conclusions: In the largest study examining this question to date, triglycerides were
found to be an independent risk factor for cardiovascular diseases in the Asia-Pacific
region. The value of incorporating triglycerides into clinical algorithms for prediction of
individual risk of cardiovascular disease and the specific role of therapy aimed at lower-
ing serum triglyceride levels should be further investigated. 
Table: Pre-operative Hemodynamic Status of Surgical Type A Acute Aortic Dissection Patients
Variables Overall 
(n=526)
Survived 
(n=394)
Dead 
(n=132)
p Value
BLOOD PRESSURE AT 
PRESENTATION
Hypertension (SBP >
150 mmHg)
160 (32.4) 128 (34.2) 32 (26.7) 0.124
Normotension (SBP 100-149 
mmHg)
213 (42.9) 176 (46.9) 37 (30.6) 0.002
Hypotension (SBP < 100 mmHg) 88 (17.6) 50 (13.3) 38 (30.4) <0.0001
Shock or tamponade (SBP < 80 
mmHg)
82 (16.1) 47 (12.3) 35 (27.6) <0.0001
BLOOD PRESSURE AFTER 
HOSPITALIZATION
In-hospital pre-op. hypotension 
(SBP < 100 mmHg)
123 (24.7) 73 (19.5) 50 (40.7) <0.0001
Hypotension from onset to surgery 213 (40.6) 123 (31.3) 90 (68.2) <0.0001
HEMODYNAMICS AT SURGERY
Hypotension/Shock at surgery 153 (31.0) 79 (21.4) 74 (59.2) <0.001
Normotension at surgery 262 (53.9) 219 (60.5) 43 (34.7) <0.001
LV dysfunction at surgery 63 (13.0) 34 (9.3) 29 (24.2) <0.001
RV dysfunction at surgery 31 (6.4) 10 (2.8) 21 (17.5) <0.001
Characteristic (% or median) Males Females Total
Age >65 years 42% 38% 41%
Current smoker 10% 8% 9%
BMI >30 kg/m2 42% 60% 48%
Diabetes duration (years) 7.2 6.7 7.0
History of hypertension 52% 64% 57%
Prior cardiovascular disease 20% 15% 18%
Receiving insulin 14% 13% 13%
Total cholesterol (mmol/L) 5.0 5.3 5.1
HDL-C (mmol/L) 1.0 1.2 1.1
TG (mmol/L) 1.7 1.8 1.7
Urinary albumin >20 mg/L 36% 27% 33%
HbA1c 6.9% 6.9% 6.9%
